Abstract
THIS ARTICLE HAS BEEN RETRACTED
Current Proteomics
Title:Retraction Notice: Protein Identification in Sub Proteome Fractions of Breast Cancer Cells by OFFGEL-IEF and iTRAQ Labeling
Volume: 6 Issue: 1
Author(s): K.H. Chandramouli*, Pushpa Agrawal and K.N. Thimmaiah
Affiliation:
- LABioMed at Harbor-UCLA, Torrance, CA,United States
Abstract: THIS ARTICLE HAS BEEN RETRACTED
Export Options
About this article
Cite this article as:
Chandramouli K.H.*, Agrawal Pushpa and Thimmaiah K.N., Retraction Notice: Protein Identification in Sub Proteome Fractions of Breast Cancer Cells by OFFGEL-IEF and iTRAQ Labeling, Current Proteomics 2009; 6 (1) . https://dx.doi.org/10.2174/157016409787847411
DOI https://dx.doi.org/10.2174/157016409787847411 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
TGF-Beta: a Master Switch in Tumor Immunity
Current Pharmaceutical Design Interaction of TGF-β with Immune Cells in Airway Disease
Current Molecular Medicine Recent Inventions in Powder Technology and Granular Science Incorporating Improved Drug Delivery
Recent Patents on Engineering Micro-/Nano-Scale Biointerfaces, Mechanical Coupling and Cancer Therapy
Current Topics in Medicinal Chemistry Opposing – Activating or Inhibitory – Effects of Cimetidine and Daidzein on Human ADH1C Activity Depending on Substrates and Solvents
Drug Metabolism Letters Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases
Current Protein & Peptide Science HMGB-1 as a Target for Inflammation Controlling
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma
Current Drug Targets Regulation of KRAS-PAK4 Axis by MicroRNAs in Cancer
Current Pharmaceutical Design A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Current Medicinal Chemistry Recent Advances in Protein and Peptide Drug Delivery Systems
Current Drug Delivery Natural and Induced Antibody Polyreactivity
Anti-Cancer Agents in Medicinal Chemistry Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Nutritional Targeting of Cyclooxygenase-2 for Colon Cancer Prevention
Inflammation & Allergy - Drug Targets (Discontinued) Novel 4- Aryl-2(1H)-phthalazinone Derivatives as Cyclooxygenase-2 Inhibitors: Synthesis, Molecular Modeling Study and Evaluation as Promising Anti-inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mucosal Immunisation: Adjuvants and Delivery Systems
Current Drug Delivery Current Status of Gene Therapy for Hepatocellular Carcinoma, with a Focus on Gene Delivery Approaches
Current Gene Therapy Docosahexaenoic Acid (DHA) Sensitizes Brain Tumor Cells to Etoposide-Induced Apoptosis
Current Molecular Medicine Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets The Roles of Sox Family Genes in Sarcoma
Current Drug Targets